| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |